Moderna executives sell $30 million under June trading plans
Alpha Vantage · WSJ · · AI-summarised by FinFlash
Moderna CFO James Mock and President Stephen Hoge sold more than $30 million in shares after a cancer vaccine study lifted the stock, and before fuller results tempered gains. The sales ran under pre-set trading plans adopted in June, before the August announcement of positive vaccine data.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.